Joseph M. Burnett

President, Chief Executive Officer, and Director at ClearPoint Neuro

Board

Since November 2017

Age

47 years

Education

Holds an MBA from The Fuqua School of Business at Duke University and a B.S.E. degree in Bio-Medical Engineering from Duke University.

Tenure

Joined in November 2017 as President, Chief Executive Officer, and Director, and has maintained that role at CLPT since then.

Also at ClearPoint Neuro

Danilo D’Alessandro

Chief Financial Officer

JLS

Jeremy L. Stigall

Chief Business Officer

Mazin Sabra

Chief Operating Officer

About

Joseph M. Burnett is a seasoned executive with a strong background in the medical device and health technology sectors. He has acquired extensive experience through leadership roles at major companies, including Philips and Volcano Corporation, where he advanced from technical roles to high-level management positions in the fields of neuro diagnostics and image-guided therapy devices.

Since joining CLPT in November 2017, he has served as President, Chief Executive Officer, and Director. In these roles, he leverages his comprehensive industry expertise to guide the company's strategic direction and operational performance.

Throughout his career, his work has exemplified a commitment to innovation and excellence in medical technology. His blend of engineering expertise and business acumen has been pivotal in shaping successful teams and delivering impactful results in a competitive market.

$CLPT Performance Under Joseph M. Burnett

Past Roles

Organization	Role	Date Range	Details
Royal Philips	Vice President and General Manager of Neuro Diagnostics and Therapy	March 2016 - November 2017	N/A
Royal Philips	Senior Vice President and Business Leader of Image Guided Therapy Devices	February 2015 - March 2016	N/A
Volcano Corporation	General Manager of Volcano Corporation (a Royal Philips company)	February 2015 - March 2016	Affiliated with Royal Philips
Volcano Corporation	Executive Vice President and General Manager of its Coronary & Systems Business Unit	November 2004 - February 2015	N/A
Guidant Corporation	R&D Engineer and Product Manager	August 1999 - November 2004	N/A
Duke University	Bio-Medical Engineering Researcher	May 1998 - May 1999	N/A
Wharton School of the University of Pennsylvania	Instructor for courses in international business and Ph.D. Candidate	N/A	Held academic position

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Salary	$517,692	Regular payroll	Base yearly salary
Stock Awards	$959,996	Non-cash; awarded on grant date	Aggregate grant date fair value of RSAs/RSUs, calculated per FASB ASC Topic 718
Option Awards	$232,225	Non-cash; awarded on grant date	Aggregate grant date fair value of option awards as per SEC Staff Accounting Bulletin 107
All Other Compensation	$12,424	Paid with regular payroll schedule	Includes 401(k) matching contributions ($9,150) and other compensation ($390); group life/disability premiums not specified; accrued PTO payout not applicable

Performance Compensation

Data from FY 2023

Non-Equity Incentive Bonus (Annual Target Incentive Bonus)

Metric	Value	Additional Details
Annual Target Incentive Bonus %	75%	Based on 2023 base salary of $517,692
Target Bonus Amount	$388,269	Calculated as 75% of base salary (0.75 * $517,692 = $388,269) [calculation, 0]
Actual Bonus Earned	$273,000	Paid in the first quarter of 2024; amount reflects performance achievement
Vesting Schedule	N/A	Cash-based bonus; not subject to vesting
Performance Metrics	Not disclosed	Specific performance thresholds, goals, evaluation period, and conditions are not provided in the documents

The bonus is contingent on performance goals set by the Compensation Committee; however, further details such as metric weights, threshold levels, and the evaluation period for the performance period are not available in the documents.